Room Air Sometimes as Good as Oxygen Therapy: Study
Comparison found no significant difference in breathlessness levels among terminally ill Source: General Cancer News Articles Provided by Cancer Compass
Comparison found no significant difference in breathlessness levels among terminally ill Source: General Cancer News Articles Provided by Cancer Compass
Statewide skin cancer rates for blacks, Hispanics differ from U.S. trends Source: General Cancer News Articles Provided by Cancer Compass
Biodesix, Inc., a company developing and commercializing molecular diagnostics for personalized medicine, announced that the United States Patent and Trademark Office has awarded to the Company patent number 7,736,905. The patent provides coverage for the Company’s first product, VeriStrat, which is used by physicians to help guide therapy [...]
The adapted virus that immunized hundreds of millions of people against smallpox has now been enlisted in the war on cancer. Vaccinia poxvirus joins a herpesvirus and a host of other pathogens on a growing list of engineered viruses entering late-stage human testing against cancer. [More]
[...]
A new therapy mounts a double-barreled attack on leukemia, targeting not just the cancer cells but also the environment in which those cells live and grow, University of Florida researchers report. Source: General Cancer News Articles Provided by Cancer Compass
Patients with stage III colon cancer treated with 5-FU-based chemotherapy after complete surgical removal of their tumor after 1995 had improved overall survival with no change in time to recurrence compared to patients treated before 1995. Source: General Cancer News Articles Provided by Cancer Compass
Smokers who don’t quit before radiation therapy for throat, mouth and other head and neck cancers fair significantly worse than those who do, research from the UC Davis Cancer Center has found. Source: General Cancer News Articles Provided by Cancer Compass
A new study, ‘Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small- cell lung cancer as frontline and second-line therapy,’ is now available. Combination chemotherapy with third-generation, nonplatinum agents (ie, gemcitabine, vinorelbine, taxanes, or camptothecins) represents a well-tolerated frontline treatment option for metastatic non- small-cell [...]
A virus that destroys cancer cells but leaves normal cells unharmed may offer hope to those affected by squamous cell carcinoma of the lungs (SCC lung cancer), according to investigators from the Cancer Therapy & Research Center (CTRC) at the University of Texas Health Science Center at San Antonio. Source: General [...]
Data detailed in ‘Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer’ have been presented. According to a study from the United States, Chemotherapy resistance is a major obstacle in cancer treatment, yet the mechanisms of response to specific therapies have [...]